PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,904,138 | -26.5% | 668,358 | -6.7% | 0.01% | -30.0% |
Q2 2023 | $9,391,716 | +46.3% | 716,378 | +24.8% | 0.01% | +42.9% |
Q1 2023 | $6,419,154 | +199.8% | 574,164 | +126.1% | 0.01% | +250.0% |
Q4 2022 | $2,141,136 | +98.1% | 253,990 | +974.6% | 0.00% | +100.0% |
Q1 2021 | $1,081,000 | – | 23,636 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |